BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Precision Medicine - ECPv6.7.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Precision Medicine
X-ORIGINAL-URL:https://sites.rutgers.edu/precision-medicine
X-WR-CALDESC:Events for Precision Medicine
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20220919T093000
DTEND;TZID=UTC:20220919T123000
DTSTAMP:20260427T183959
CREATED:20220812T104508Z
LAST-MODIFIED:20220812T104508Z
UID:1089-1663579800-1663590600@sites.rutgers.edu
SUMMARY:Dr. Ahmed speaking in the webinar\, Interpreting Precision Medicine Data\, by Drug Discovery News.
DESCRIPTION:Dr. Zeeshan Ahmed is participating in the webinar\, Interpreting Precision Medicine Data\, by hosted the Drug Discovery News (DDN). \nDr. Ahmed will be presenting\, “Integrating clinical\, multi-omic\, and genomic data analysis for patients with cardiovascular disease”. Monday\, September 19th\, 2022 | 9:30 AM – 12:30 PM Eastern Time. \nThe seminar\, Interpreting Precision Medicine Data\, is about advances in data integration enable scientists to combine multiomics data and a patient’s clinical record to develop precision medicine approaches for treating disease. From DNA sequencing\, proteomics profiling\, and clinical data analysis to wearable biosensing technology\, researchers are developing new ways to track individual health. How do researchers reliably interpret these results and apply them to new treatments and therapeutics? \nIn this seminar\, Tim Hulsen\, Zeeshan Ahmed\, Alexandra Blee\, and Bill Stanford will discuss how scientists examine genetic and molecular information to develop individualized therapeutic strategies. \nTopics to be covered \n\nApplying big data for developing precision medicine approaches\nIntegrating clinical\, multi-omic\, and genomic data analysis for patients with cardiovascular disease\nPredicting xeroderma pigmentosum group A variants using machine learning and functional validation\nModeling tuberous sclerosis tumorigenesis using stem cell-derived tissue engineering\n\nRegistration and seminar details are open at through DDN.
URL:https://sites.rutgers.edu/precision-medicine/event/dr-ahmed-speaking-in-the-webinar-interpreting-precision-medicine-data-by-drug-discovery-news/
END:VEVENT
END:VCALENDAR